97 related articles for article (PubMed ID: 20008224)
1. Independent prognostic factors for AML outcome.
Grimwade D; Hills RK
Hematology Am Soc Hematol Educ Program; 2009; ():385-95. PubMed ID: 20008224
[TBL] [Abstract][Full Text] [Related]
2. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.
Liersch R; Müller-Tidow C; Berdel WE; Krug U
Br J Haematol; 2014 Apr; 165(1):17-38. PubMed ID: 24484469
[TBL] [Abstract][Full Text] [Related]
4. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
Grimwade D; Walker H; Oliver F; Wheatley K; Harrison C; Harrison G; Rees J; Hann I; Stevens R; Burnett A; Goldstone A
Blood; 1998 Oct; 92(7):2322-33. PubMed ID: 9746770
[TBL] [Abstract][Full Text] [Related]
5. New prognostic markers in acute myeloid leukemia: perspective from the clinic.
Foran JM
Hematology Am Soc Hematol Educ Program; 2010; 2010():47-55. PubMed ID: 21239770
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
7. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.
Bochtler T; Fröhling S; Krämer A
Leukemia; 2015 Jun; 29(6):1243-52. PubMed ID: 25673237
[TBL] [Abstract][Full Text] [Related]
8. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.
Abdel-Wahab O; Levine RL
Blood; 2013 May; 121(18):3563-72. PubMed ID: 23640996
[TBL] [Abstract][Full Text] [Related]
9. The role of HOX genes in normal hematopoiesis and acute leukemia.
Alharbi RA; Pettengell R; Pandha HS; Morgan R
Leukemia; 2013 Apr; 27(5):1000-8. PubMed ID: 23212154
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
Mrózek K; Marcucci G; Nicolet D; Maharry KS; Becker H; Whitman SP; Metzeler KH; Schwind S; Wu YZ; Kohlschmidt J; Pettenati MJ; Heerema NA; Block AW; Patil SR; Baer MR; Kolitz JE; Moore JO; Carroll AJ; Stone RM; Larson RA; Bloomfield CD
J Clin Oncol; 2012 Dec; 30(36):4515-23. PubMed ID: 22987078
[TBL] [Abstract][Full Text] [Related]
11. NCCN Clinical Practice Guidelines Acute myeloid leukemia.
O'Donnell MR; Abboud CN; Altman J; Appelbaum FR; Arber DA; Attar E; Borate U; Coutre SE; Damon LE; Goorha S; Lancet J; Maness LJ; Marcucci G; Millenson MM; Moore JO; Ravandi F; Shami PJ; Smith BD; Stone RM; Strickland SA; Tallman MS; Wang ES; Naganuma M; Gregory KM
J Natl Compr Canc Netw; 2012 Aug; 10(8):984-1021. PubMed ID: 22878824
[TBL] [Abstract][Full Text] [Related]
12. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
[TBL] [Abstract][Full Text] [Related]
14. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection.
Srinivasan Rajsri K; Roy N; Chakraborty S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345204
[TBL] [Abstract][Full Text] [Related]
15. Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis.
Aydin S; Passera R; Cerrano M; Giai V; D'Ardia S; Iovino G; Dellacasa CM; Audisio E; Busca A
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831347
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up.
Albuquerque KMC; Joventino CB; Moreira LC; Rocha HAL; Gurgel LA; Oliveira DS; Rodrigues CEM
Hematol Transfus Cell Ther; 2024; 46(1):8-13. PubMed ID: 36564332
[TBL] [Abstract][Full Text] [Related]
17. MYC overexpression is associated with an early disease progression from MDS to AML.
Gajzer D; Logothetis CN; Sallman DA; Calon G; Babu A; Chan O; Vincelette ND; Volpe VO; Al Ali NH; Basra P; Talati C; Kuykendall AT; Mo Q; Padron E; Sweet K; Komrokji RS; Lancet JE; Yun S; Zhang L
Leuk Res; 2021 Dec; 111():106733. PubMed ID: 34749168
[TBL] [Abstract][Full Text] [Related]
18. C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study.
Wang J; Wang W; Chen H; Li W; Huang T; Zhang W; Ling W; Lai P; Wang Y; Geng S; Li M; Du X; Weng J
Biomed Res Int; 2021; 2021():6643948. PubMed ID: 33778076
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Heuser M; Smith BD; Fiedler W; Sekeres MA; Montesinos P; Leber B; Merchant A; Papayannidis C; Pérez-Simón JA; Hoang CJ; O'Brien T; Ma WW; Zeremski M; O'Connell A; Chan G; Cortes JE
Ann Hematol; 2021 May; 100(5):1181-1194. PubMed ID: 33740113
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies.
Alsagaby SA
Stem Cells Int; 2021; 2021():6633386. PubMed ID: 33679988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
